Search results
Results From The WOW.Com Content Network
Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium Streptococcus agalactiae. Streptococcus agalactiae is the most common human pathogen belonging to group B of the Lancefield classification of streptococci —hence the name of group B ...
Neonatal infection treatment is typically started before the diagnosis of the cause can be confirmed. Neonatal infection can be prophylactically treated with antibiotics. [55] Maternal treatment with antibiotics is primarily used to protect against group B streptococcus. [30]
Those meeting these criteria likely do not require a lumbar puncture, and are felt to be safe for discharge home without antibiotic treatment, or with a single dose of intramuscular antibiotics, but will still require close outpatient follow-up. [citation needed] One risk for Group B streptococcal infection (GBS) is preterm rupture of membranes ...
Streptococcus agalactiae (also known as group B streptococcus or GBS) is a gram-positive coccus (round bacterium) with a tendency to form chains (as reflected by the genus name Streptococcus). It is a beta- hemolytic , catalase -negative, and facultative anaerobe .
Ampicillin is an antibiotic belonging to the aminopenicillin class of the penicillin family. The drug is used to prevent and treat several bacterial infections, such as respiratory tract infections, urinary tract infections, meningitis, salmonellosis, and endocarditis. [7] It may also be used to prevent group B streptococcal infection in ...
Antibiotics have been used to prevent and treat these infections—however, the misuse of antibiotics is a serious problem for global health. [2] It is recommended that guidelines be followed that outline when it is appropriate to give antibiotics and which antibiotics are most effective. [2]
Cefazolin, also known as cefazoline and cephazolin, is a first-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. [2] Specifically it is used to treat cellulitis, urinary tract infections, pneumonia, endocarditis, joint infection, and biliary tract infections. [2]
The elimination half-life of moxifloxacin is 11.5 to 15.6 hours (single-dose, oral). [45] About 45% of an oral or intravenous dose of moxifloxacin is excreted as unchanged drug (about 20% in urine and 25% in feces). A total of 96 ± 4% of an oral dose is excreted as either unchanged drug or known metabolites.